Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03248674 · ClinicalTrials.gov registry record
Diagnostic Performance of Coronary CT Angiography With CT FFR in Kidney Transplantation Candidates
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 26
- Enrollment target
NCT03248674: Clinical Trial study, sponsored by Stanford University.
NCT03248674 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03248674 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Patients with chronic kidney disease (CKD) before kidney transplantation require that obstructive coronary artery disease (CAD) is excluded, as cardiovascular complications are the leading cause of mortality in kidney transplant patients. However, in this patient population, the optimal method for the detection of obstructive CAD has not been identified. Noninvasive stress tests such as Dobutamine stress echocardiography or nuclear perfusion study have low diagnostic accuracy. CT fractional flow reserve measurement (CT FFR) is a novel non-invasive (FDA approved) imaging test to identify obstructive CAD. The goal of this project is to evaluate the diagnostic accuracy of CT FFR in the detection of obstructive coronary artery disease in patients with chronic kidney disease before kidney transplantation.
Interventions
- DIAGNOSTIC_TEST CT FFR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-08-28 |
| Est. Completion | 2020-01-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03248674
The ClinicalTrials.gov registry entry for NCT03248674 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CT FFR is the first listed.
NCT03248674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03248674 about?
NCT03248674 is a clinical study titled "Diagnostic Performance of Coronary CT Angiography With CT FFR in Kidney Transplantation Candidates". Patients with chronic kidney disease (CKD) before kidney transplantation require that obstructive coronary artery disease (CAD) is excluded, as cardiovascular complications are the leading cause of mortality in kidney transplant patients. However, in this patient population, the optimal method for t...
What is the current status of trial NCT03248674?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2017-08-28. Estimated completion is 2020-01-24.
What interventions are being tested in trial NCT03248674?
The interventions under investigation include: CT FFR (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03248674?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.